Monday November 18th – Wednesday November 20th, 2019
Bethesda North Marriott Hotel & Conference Center
This conference will bring together nine networks that are part of the Cancer Moonshot
SM, fostering collaboration, communication and outreach within and across consortia involved in the Cancer Moonshot
SM:
CIMAC-CIDC - Immuno-Oncology Biomarkers Network
DRSN - Drug Resistance and Sensitivity Network
FusOnC2 - Fusion Oncoproteins in Childhood Cancer
HTAN - Human Tumor Atlas Network
IOTN - Immuno-Oncology Translational Network
PaCMEN - Pancreatic Cancer Microenvironment Network
PDXNet - Patient-Derived Xenograft Development and Trials Centers
PI-DDN - Pediatric Immunotherapy Discovery and Development Network
PRECINCT - Pre-Medical Cancer Immunotherapy Network for Canine Trials
Days 1 and 2 of the conference will comprise a face-to-face meeting of the Immuno-Oncology Translational Network (IOTN) Steering Committee, with the other participating networks also holding individual consortium meetings on one or both of these days.
A "Collaborative Poster Session", bringing together all the participating networks, will be held in the late afternoon of Tuesday November 19th, marking the start of the collaborative "Cross-Moonshot" portion of the conference.
A "Collaborative General Session" will be held all day on Wednesday November 20th, involving all nine participating Cancer Moonshot Consortia.
Program details are under development – please stay tuned for updates about this exciting event!
Questions?
For questions related to registration, the hotel and logistics, please contact:
Tina Amyes, PhD tina.amyes@roswellpark.org
For questions related to NIH specific coordination and the agenda, please contact:
Lillian Kuo, PhD lillian.kuo@nih.gov
